NCT03707678 A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma Status WITHDRAWN Phase PHASE2
NCT03703245 Pooled Analysis of Clinical Data From Six GSK Studies to Investigate the Efficacy of a Dentifrice Containing 67% Weight by Weight (w/w) Sodium Bicarbonate on Gingivitis and Plaque Accumulation Status COMPLETED Phase N/A
NCT03702036 Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma Status NO_LONGER_AVAILABLE Phase N/A
NCT03699241 A Randomized, Double-blinded, Placebo-controlled, Dose-escalation Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant HIV Envelope Protein BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, in Healthy, HIV-1 Uninfected Adults Status COMPLETED Phase PHASE1
NCT03697824 Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a Status WITHDRAWN Phase PHASE2
NCT03693612 GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03688620 Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season Status COMPLETED Phase PHASE4
NCT03681951 First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors Status TERMINATED Phase PHASE2
NCT03681067 A Clinical Trial of Antibody GSK1070806 in the Treatment of Patients With Moderate to Severe Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT03680508 TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03674177 A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women Status COMPLETED Phase PHASE1
NCT03671369 A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea Status COMPLETED Phase N/A
NCT03666988 First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL) Status TERMINATED Phase PHASE1
NCT03654833 Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma Status UNKNOWN Phase PHASE2
NCT03652610 A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age Status COMPLETED Phase PHASE2
NCT03649412 A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772 Status COMPLETED Phase PHASE1
NCT03644342 Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix Status TERMINATED Phase PHASE1/PHASE2
NCT03640832 A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin Status COMPLETED Phase NA